Anti-Müllerian hormone, or AMH, has become one of the more commonly discussed fertility markers in recent years, particularly for women evaluating their options after 35. It’s often described in shorthand as a measure of “ovarian reserve,” but what that actually means — and what it doesn’t — is worth understanding before drawing conclusions from a single number.
AMH testing can be a useful piece of information, but research is clear that it is only one part of a much larger fertility picture. This article walks through what AMH measures, what current evidence suggests about its role after 35, and how it fits alongside other factors in family planning conversations.
As with most hormonal markers, individual variation is the rule rather than the exception, and a lower or higher AMH result does not, by itself, predict whether or when someone will conceive.
What Research Shows About AMH and Age
AMH is produced by cells in small ovarian follicles, and research generally shows that levels decline gradually as women age, reflecting the natural decrease in the number of remaining eggs over time. According to information published by the National Institutes of Health, AMH correlates with the quantity of remaining follicles but is not considered a reliable predictor of egg quality or natural conception likelihood on its own.
What AMH Can and Cannot Tell You
AMH testing is frequently used in fertility clinics to help estimate how a person might respond to ovarian stimulation during IVF, which is a somewhat different question than whether someone can conceive naturally. Some women researching egg freezing after 35 use AMH as one data point when discussing timing and expectations with a fertility specialist, though it is generally considered alongside antral follicle counts and other clinical factors.
Why a Low AMH Isn’t the Whole Story
It’s a common misconception that a low AMH result means natural conception is unlikely. Current evidence suggests AMH primarily reflects egg quantity rather than quality, and many women with lower AMH levels conceive naturally, sometimes without any fertility intervention at all. Egg quality tends to be more closely associated with age itself than with AMH levels specifically.
How AMH Testing Typically Fits Into Fertility Evaluation
Reproductive endocrinologists typically interpret AMH within a broader evaluation that may include antral follicle count via ultrasound, FSH levels, and a review of menstrual cycle history. The American College of Obstetricians and Gynecologists notes that ovarian reserve testing can help inform conversations about family planning timelines but should not be used in isolation to make major decisions. Some women also find it helpful to discuss AMH results alongside the emotional aspects of trying to conceive after 35, since test results can understandably bring up anxiety regardless of what they actually indicate clinically.
When AMH Testing Might Be Worth Considering
Some women choose to test AMH proactively as part of family planning conversations, particularly if they are considering delaying conception or exploring egg freezing. Others test after experiencing difficulty conceiving. In either case, a reproductive endocrinologist can help interpret results in the context of individual goals and circumstances, rather than as a standalone verdict on fertility potential.
Frequently Asked Questions
What is considered a “normal” AMH level after 35?
Reference ranges vary by lab and tend to decrease gradually with age on average, though individual variation is significant. A reproductive endocrinologist can help interpret your specific result relative to age-adjusted norms and your overall fertility picture.
Does a low AMH mean I can’t get pregnant naturally?
Not necessarily. AMH is associated with egg quantity, not a guarantee of conception likelihood, and many women with lower AMH levels conceive without medical intervention. Egg quality and other factors also play meaningful roles.
Can AMH levels change over time or with lifestyle changes?
AMH tends to decline gradually with age and is generally considered a relatively stable marker within a given time frame, though some research has explored whether certain factors may cause modest fluctuations. This remains an area of ongoing study.
Should every woman over 35 get an AMH test?
This depends on individual circumstances and goals. Some healthcare providers recommend it as part of proactive family planning discussions, while others reserve it for women experiencing difficulty conceiving. It’s a good topic to raise with your provider.
Key Takeaways
- AMH reflects an estimate of remaining egg quantity, not egg quality or a guarantee of fertility outcomes.
- Research suggests AMH levels generally decline with age, though individual variation is substantial.
- AMH is most useful as one piece of a broader fertility evaluation rather than a standalone predictor.
- A reproductive endocrinologist can help interpret AMH results within the context of your personal fertility goals and history.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.